CHU Clermont-Ferrand
Clermont-Ferrand, France
NCT Number: NCT05156931
The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Clermont-Ferrand, France
Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: day 1
declaration of a practice of self-medication
Time frame: day 1
non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements
Time frame: day 1
For treatment of side-effects, improvements in anti-cancer effects
Time frame: day 1
pharmacy, market, internet, other
Time frame: day 1
yes / no
Time frame: day 1
Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties
University Hospital, Clermont-Ferrand
Other
Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response
Acronym: CASEME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT01445483
Brain Diseases, Brain Metastasis
Bethesda, Maryland, United States
View Trial DetailsNCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsNCT03556384
Brain Diseases, Cancer
La Jolla, California, United States
View Trial Details